05Sep Atul informs about issuance of duplicaPursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
09Aug Atul’s arm gets EIR from USFDA for AmbAtul’s 100% subsidiary -- Atul Bioscience (ABL) has received Establishme..
22Jul Atul informs about newspaper publicatiPursuant to Regulation 47 of the Securities and Exchange Board of India..
19Jul Atul reports 10% rise in Q1 consolidatAtul has reported results for first quarter ended June 30, 2024 (Q1FY25)..
19Jul Atul informs about unaudited financialPursuant to the Regulation 30 and 33(1) of the Securities Exchange Board..